Published in EMBO J on December 01, 1987
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer (2006) 4.27
Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO J (1988) 3.61
Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev (2004) 3.52
Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J Virol (1990) 2.90
Transient replication of human papillomavirus DNAs. J Virol (1992) 2.43
Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc Natl Acad Sci U S A (1992) 2.30
Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies. J Virol (1988) 1.98
Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J Virol (1989) 1.83
Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers. Nucleic Acids Res (1990) 1.81
CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol (2003) 1.72
During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. Nucleic Acids Res (1992) 1.69
The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J Virol (1990) 1.68
Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation. J Virol (1989) 1.52
Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites. Nucleic Acids Res (1990) 1.51
Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. Nucleic Acids Res (1989) 1.50
Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites. J Virol (2001) 1.47
Estrogen and ERalpha: culprits in cervical cancer? Trends Endocrinol Metab (2010) 1.33
The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. J Virol (1999) 1.32
Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16. J Virol (1993) 1.31
Presence of catenated human papillomavirus type 16 episomes in a cervical carcinoma cell line. J Virol (1989) 1.30
YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J Virol (1996) 1.24
Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells. Proc Natl Acad Sci U S A (1988) 1.24
Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors. J Clin Pathol (1995) 1.19
Influence of ovarian hormones on urogenital infection. Sex Transm Infect (1998) 1.19
Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA. J Virol (2000) 1.17
Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc Natl Acad Sci U S A (1991) 1.17
Role of the E1--E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31. J Virol (2005) 1.16
The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element. J Virol (2000) 1.15
Transforming growth factors beta 1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells. J Virol (1990) 1.11
Critical roles of nuclear receptor response elements in replication of hepatitis B virus. J Virol (2001) 1.08
Cloning and functional analysis of spliced isoforms of human nuclear factor I-X: interference with transcriptional activation by NFI/CTF in a cell-type specific manner. Nucleic Acids Res (1994) 1.06
Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplification. J Virol (2005) 1.06
The bovine papillomavirus constitutive enhancer is essential for viral transformation, DNA replication, and the maintenance of latency. J Virol (1992) 1.04
Molecular events in uterine cervical cancer. Sex Transm Infect (1998) 1.01
Differential effects of nerve growth factor and dexamethasone on herpes simplex virus type 1 oriL- and oriS-dependent DNA replication in PC12 cells. J Virol (1997) 0.99
Transcriptional regulatory elements in the noncoding region of human papillomavirus type 6. J Virol (1988) 0.99
Two novel promoters in the upstream regulatory region of human papillomavirus type 31b are negatively regulated by epithelial differentiation. J Virol (1999) 0.97
The constitutively expressed octamer binding protein OTF-1 and a novel octamer binding protein expressed specifically in cervical cells bind to an octamer-related sequence in the human papillomavirus 16 enhancer. Nucleic Acids Res (1991) 0.97
The octamer binding site in the HPV16 regulatory region produces opposite effects on gene expression in cervical and non-cervical cells. Nucleic Acids Res (1993) 0.96
Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics. Nucleic Acids Res (2007) 0.96
Nuclear matrix attachment regions of human papillomavirus type 16 point toward conservation of these genomic elements in all genital papillomaviruses. J Virol (1998) 0.94
A steroid hormone response unit in the late leader of the noncoding control region of the human polyomavirus BK confers enhanced host cell permissivity. J Virol (1994) 0.91
Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions. J Virol (1993) 0.90
NF-IL6 represses early gene expression of human papillomavirus type 16 through binding to the noncoding region. J Virol (1993) 0.89
A novel YY1-independent silencer represses the activity of the human papillomavirus type 16 enhancer. J Virol (1998) 0.87
Functional mapping of the human papillomavirus type 16 E1 cistron. J Virol (2008) 0.86
The HPV-activating cellular transcription factor Brn-3a is overexpressed in CIN3 cervical lesions. J Clin Invest (1998) 0.84
Induction of anchorage-independent growth of human embryonic fibroblasts with a deletion in the short arm of chromosome 11 by human papillomavirus type 16 DNA. J Virol (1988) 0.84
A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein. J Virol (2001) 0.83
Constitutive expression of c-myc oncogene confers hormone independence and enhanced growth-factor responsiveness on cells transformed by human papilloma virus type 16. Proc Natl Acad Sci U S A (1989) 0.82
Is oral contraceptive associated with genital warts? Genitourin Med (1996) 0.80
Inhibition of radiation-induced apoptosis by dexamethasone in cervical carcinoma cell lines depends upon increased HPV E6/E7. Br J Cancer (2000) 0.79
The upstream regulatory region of human papillomavirus type 31 is insensitive to glucocorticoid induction. J Virol (2002) 0.79
Transactivation of the human papilloma virus 16 octamer motif by the octamer binding protein Oct-2 requires both the N and C terminal activation domains. Nucleic Acids Res (1993) 0.79
Novel binding sites for regulatory factors in the human papillomavirus type 18 enhancer and promoter identified by in vivo footprinting. J Virol (1998) 0.79
Rhesus papillomavirus type 1 cooperates with activated ras in transforming primary epithelial rat cells independent of dexamethasone. J Virol (1991) 0.78
Oral contraceptives and human papillomavirus infection in cervical intraepithelial neoplasia. Arch Gynecol Obstet (1992) 0.78
Induction of the upstream regulatory region of human papillomavirus type 31 by dexamethasone is differentiation dependent. J Virol (2003) 0.77
Characterization of keratin and cell cycle protein expression in cell lines from squamous intraepithelial lesions progressing towards a malignant phenotype. Br J Cancer (1998) 0.76
Human genomic diversity, viral genomics and proteomics, as exemplified by human papillomaviruses and H5N1 influenza viruses. Hum Genomics (2009) 0.75
The HPV Cellular Transactivator Brn-3a Can Be Used to Predict Cervical Adenocarcinoma and Squamous Carcinoma Precancer Lesions in the Developed and Developing Worlds. Obstet Gynecol Int (2010) 0.75
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res (1984) 86.56
Transcriptional control signals of a eukaryotic protein-coding gene. Science (1982) 25.38
Identification of two distinct regulatory regions adjacent to the human beta-interferon gene. Cell (1983) 17.60
CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res (1987) 15.65
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A (1983) 14.73
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature (1985) 11.11
Enhancer elements. Cell (1983) 10.41
Regulation of simian virus 40 early transcription in vitro by a purified tumor antigen. Proc Natl Acad Sci U S A (1980) 10.22
Human papillomavirus type 16 DNA sequence. Virology (1985) 9.44
Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci U S A (1986) 7.78
Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J (1986) 7.60
Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene. Nature (1984) 7.57
Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product. Cell (1985) 7.56
DNA sequences bound specifically by glucocorticoid receptor in vitro render a heterologous promoter hormone responsive in vivo. Cell (1983) 7.39
Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell (1987) 6.12
Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell (1983) 6.01
The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumour virus. Nature (1983) 5.76
Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature (1987) 5.61
Activation of the SV40 late promoter: direct effects of T antigen in the absence of viral DNA replication. Cell (1984) 5.30
An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell (1986) 5.22
Characterization of the bovine papilloma virus plasmid maintenance sequences. Cell (1984) 5.01
T antigen repression of SV40 early transcription from two promoters. Cell (1981) 4.83
Localization and analysis of bovine papillomavirus type 1 transforming functions. J Virol (1984) 4.77
Bovine papilloma virus contains an activator of gene expression at the distal end of the early transcription unit. Mol Cell Biol (1983) 4.56
Virus-specific transcription in bovine papillomavirus-transformed mouse cells. Virology (1982) 4.52
Biology and biochemistry of papillomaviruses. Rev Physiol Biochem Pharmacol (1984) 4.13
The hormone regulatory element of mouse mammary tumour virus mediates progesterone induction. EMBO J (1986) 4.04
Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer. Mol Cell Biol (1987) 4.02
Stimulation of simian virus 40 late gene expression by simian virus 40 tumor antigen. Proc Natl Acad Sci U S A (1984) 3.80
Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues. EMBO J (1987) 3.77
Messenger RNAs from the transforming region of bovine papilloma virus type I. J Mol Biol (1985) 3.73
Trans-activation of an upstream early gene promoter of bovine papilloma virus-1 by a product of the viral E2 gene. EMBO J (1987) 3.65
Subfragments of the large terminal repeat cause glucocorticoid-responsive expression of mouse mammary tumor virus and of an adjacent gene. Proc Natl Acad Sci U S A (1983) 3.42
In vivo protein-DNA interactions in a glucocorticoid response element require the presence of the hormone. Nature (1987) 3.39
Glucocorticoid responsiveness of the transcriptional enhancer of Moloney murine sarcoma virus. Cell (1986) 3.31
The E2 "gene" of bovine papillomavirus encodes an enhancer-binding protein. Proc Natl Acad Sci U S A (1987) 3.31
Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product. J Virol (1987) 3.24
A small region of the mouse mammary tumor virus long terminal repeat confers glucocorticoid hormone regulation on a linked heterologous gene. Proc Natl Acad Sci U S A (1983) 2.79
Early events in the stimulation of mammary tumor virus RNA synthesis by glucocorticoids. Novel assays of transcription rates. J Biol Chem (1984) 2.68
Contacts between hormone receptor and DNA double helix within a glucocorticoid regulatory element of mouse mammary tumor virus. Proc Natl Acad Sci U S A (1984) 2.64
Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells. EMBO J (1987) 2.56
Hormonal response region in the mouse mammary tumor virus long terminal repeat can be dissociated from the proviral promoter and has enhancer properties. Proc Natl Acad Sci U S A (1985) 2.47
Fine structure of the cottontail rabbit papillomavirus mRNAs expressed in the transplantable VX2 carcinoma. J Virol (1985) 2.40
A superfamily of potentially oncogenic hormone receptors. Nature (1987) 2.40
Glucocorticoid regulation of mouse mammary tumor virus: identification of a short essential DNA region. EMBO J (1983) 2.12
The first intron of the human growth hormone gene contains a binding site for glucocorticoid receptor. Proc Natl Acad Sci U S A (1985) 2.03
Glucocorticoid induction of the rat tryptophan oxygenase gene is mediated by two widely separated glucocorticoid-responsive elements. EMBO J (1987) 1.87
Two different factors act separately or together to specify functionally distinct activities at a single transcriptional enhancer. Mol Cell Biol (1986) 1.86
Polyoma regulatory region: a potential probe for mouse cell differentiation. Cell (1985) 1.82
MCF-7; a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors. Steroids (1975) 1.72
Androgen regulation by the long terminal repeat of mouse mammary tumor virus. Mol Cell Biol (1986) 1.43
A pancreas specificity results from the combination of polyomavirus and Moloney murine leukemia virus enhancer. Proc Natl Acad Sci U S A (1987) 1.12
Transient expression of the chicken lysozyme gene after transfer into human cells. EMBO J (1982) 0.90
Human papillomavirus type 16 DNA sequence. Virology (1985) 9.44
Construction of a fusion gene that confers resistance against hygromycin B to mammalian cells in culture. Exp Cell Res (1985) 4.42
Isolation of a genomic clone partially encoding human hypoxanthine phosphoribosyltransferase. Proc Natl Acad Sci U S A (1982) 3.49
Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol (1995) 3.26
A DNA sequence of 15 base pairs is sufficient to mediate both glucocorticoid and progesterone induction of gene expression. Proc Natl Acad Sci U S A (1987) 3.07
EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol (1994) 3.06
Construction of plasmid cloning vehicles that promote gene expression from the bacteriophage lambda pL promoter. Gene (1979) 3.00
Use of the lambda phage promoter PL to promote gene expression in hybrid plasmid cloning vehicles. Methods Enzymol (1979) 2.74
Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells. EMBO J (1987) 2.56
Purification of the TET repressor and TET operator from the transposon Tn10 and characterization of their interaction. J Biol Chem (1982) 2.10
The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J Virol (1994) 2.01
New cosmid vectors developed for eukaryotic DNA cloning. Gene (1984) 1.97
The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol (1999) 1.94
Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evolution of DNA viruses. J Virol (1992) 1.88
Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J Virol (1989) 1.83
Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers. Nucleic Acids Res (1990) 1.81
Heterologous repressor-operator recognition among four classes of tetracycline resistance determinants. J Bacteriol (1985) 1.76
Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst (1989) 1.72
During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. Nucleic Acids Res (1992) 1.69
The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J Virol (1990) 1.68
Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC gamma. EMBO J (1994) 1.68
Construction of an E. coli strain overproducing the Tn10-encoded TET repressor and its use for large scale purification. EMBO J (1984) 1.64
Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein. J Natl Cancer Inst (1999) 1.62
Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol (1991) 1.57
Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites. Nucleic Acids Res (1990) 1.51
Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. Nucleic Acids Res (1989) 1.50
Phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling. J Biol Chem (1998) 1.43
Nucleotide sequence of the repressor gene of the RA1 tetracycline resistance determinant: structural and functional comparison with three related Tet repressor genes. Nucleic Acids Res (1984) 1.35
A bovine papilloma virus vector with a dominant resistance marker replicates extrachromosomally in mouse and E. coli cells. EMBO J (1983) 1.33
Expression, purification and operator binding of the transposon Tn1721-encoded Tet repressor. J Mol Biol (1986) 1.32
The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. J Virol (1999) 1.32
Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16. J Virol (1993) 1.31
High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology (1996) 1.27
YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J Virol (1996) 1.24
Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. Virology (1995) 1.24
Interleukin-1beta-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Biol Chem (1998) 1.19
Bradykinin B(2) receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation. Mol Cell Biol (1999) 1.18
PLD2 complexes with the EGF receptor and undergoes tyrosine phosphorylation at a single site upon agonist stimulation. J Biol Chem (1998) 1.18
Expression of the human papillomavirus type 18 E7 gene by a cassette-vector system for the transcription and translation of open reading frames in eukaryotic cells. EMBO J (1987) 1.17
Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA. J Virol (2000) 1.17
Genomic diversity and evolution of papillomaviruses in rhesus monkeys. J Virol (1997) 1.16
The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element. J Virol (2000) 1.15
Human papillomaviruses in 91 oral cancers from Indian betel quid chewers--high prevalence and multiplicity of infections. Int J Cancer (1995) 1.14
Identification of human papillomavirus type 16 E7 protein by monoclonal antibodies. J Gen Virol (1987) 1.14
Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300. J Virol (1999) 1.11
Molecular diagnosis of genital HPV DNA types by polymerase chain reaction and sensitivity-standardized filter in situ hybridization in randomly sampled cohorts of Singapore women. Mol Cell Probes (1990) 1.11
Glucocorticoid- and progesterone-specific effects are determined by differential expression of the respective hormone receptors. Nature (1989) 1.09
Cloning and functional analysis of spliced isoforms of human nuclear factor I-X: interference with transcriptional activation by NFI/CTF in a cell-type specific manner. Nucleic Acids Res (1994) 1.06
Sequence variants of human papillomavirus type 16 from couples suggest sexual transmission with low infectivity and polyclonality in genital neoplasia. J Infect Dis (1993) 1.02
NFI-B3, a novel transcriptional repressor of the nuclear factor I family, is generated by alternative RNA processing. J Biol Chem (1997) 1.02
Genital papillomaviruses (PVs) and epidermodysplasia verruciformis PVs occur in the same monkey species: implications for PV evolution. Virology (1997) 1.00
Mutations and polymorphisms in the p53, p21 and p16 genes in oral carcinomas of Indian betel quid chewers. Int J Cancer (1996) 0.97
Methylation sensitivity of the enhancer from the human papillomavirus type 16. J Biol Chem (1994) 0.95
Phylogenetic analysis of the human papillomavirus type 2 (HPV-2), HPV-27, and HPV-57 group, which is associated with common warts. Virology (1997) 0.94
Nuclear matrix attachment regions of human papillomavirus type 16 point toward conservation of these genomic elements in all genital papillomaviruses. J Virol (1998) 0.94
Inactivation of the human papillomavirus-16 E6 oncoprotein by organic disulfides. Bioorg Med Chem (2000) 0.92
[Interdisciplinary AWMF guideline for the diagnostics of primary immunodeficiency]. Klin Padiatr (2011) 0.91
The Mastomys natalensis papillomavirus: nucleotide sequence, genome organization, and phylogenetic relationship of a rodent papillomavirus involved in tumorigenesis of cutaneous epithelia. Virology (1994) 0.91
Glucose-induced translocation of protein kinase C isoforms in rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase. J Biol Chem (1994) 0.90
Diagnostic sensitivity of polymerase chain reaction and Southern blot hybridization for the detection of human papillomavirus DNA in biopsy specimens from cervical lesions. Am J Clin Pathol (1991) 0.90
Identification of genomic sequences of three novel human papillomavirus sequences in cervical smears of Amazonian Indians. J Infect Dis (1994) 0.89
Interaction with CBP/p300 enables the bovine papillomavirus type 1 E6 oncoprotein to downregulate CBP/p300-mediated transactivation by p53. J Gen Virol (2000) 0.88
Many different papillomaviruses have low transcriptional activity in spite of strong epithelial specific enhancers. J Gen Virol (1999) 0.88
A novel YY1-independent silencer represses the activity of the human papillomavirus type 16 enhancer. J Virol (1998) 0.87
A plasmodial alpha-tubulin cDNA from Physarum polycephalum. Nucleotide sequence and comparative analysis. J Mol Biol (1985) 0.87
Nerve growth factor and epidermal growth factor stimulate clusterin gene expression in PC12 cells. Biochem J (1999) 0.87
Definition of signals for neuronal differentiation. Ann N Y Acad Sci (1995) 0.84
Insulin-induced phospholipase D1 and phospholipase D2 activity in human embryonic kidney-293 cells mediated by the phospholipase C gamma and protein kinase C alpha signalling cascade. Biochem J (2000) 0.84
Apoptotic cell debris and phosphatidylserine-containing lipid vesicles induce apolipoprotein J (clusterin) gene expression in vital fibroblasts. Exp Cell Res (2001) 0.83
Subclinical human papillomavirus infection of the male lower genital tract: colposcopy, histology and DNA analysis. Int J STD AIDS (1991) 0.83
Analysis of the human guanylin gene and the processing and cellular localization of the peptide. Proc Natl Acad Sci U S A (1995) 0.83
Thermus aquaticus DNA polymerase-catalysed chain reaction for the detection of human papillomaviruses. J Virol Methods (1990) 0.82
Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes. J Gen Virol (1994) 0.82
Physical state, expression and regulation of two glucocorticoid-controlled genes on bovine papilloma virus vectors. J Mol Biol (1986) 0.82
Cooperative action of the glucocorticoid receptor and transcription factors. Cold Spring Harb Symp Quant Biol (1988) 0.81
Human papillomavirus-16 and genital cancer: are tests for the viral gene expression in vitro indicators for risk factors in vivo? Ann Acad Med Singapore (1988) 0.80
Coordinate expression of alkali and DTNB myosin light chains during transformation of rabbit fast muscle by chronic stimulation. FEBS Lett (1983) 0.79
Human papillomavirus type 2c is identical to human papillomavirus type 27. Virology (1994) 0.79
Elucidating the population histories and transmission dynamics of papillomaviruses using phylogenetic trees. J Mol Evol (1997) 0.79
Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer. J Gen Virol (1995) 0.78
Multiple signal transduction pathways regulate clusterin (gp 80) gene expression in MDCK cells. J Mol Endocrinol (1996) 0.77
Constitutive and steroid hormone regulated transcriptional enhancer elements in the genome of the human papilloma virus type 16, which is associated with neoplasia of the cervix. Cancer Detect Prev (1988) 0.76
Analysis of tet operator-TET repressor complexes by thermal denaturation studies. Nucleic Acids Res (1982) 0.75
Genital human papillomavirus infection among women from major ethnic groups in Singapore. Asia Oceania J Obstet Gynaecol (1990) 0.75
Nucleic acid hybridization and the polymerase chain reaction in biology and medicine, with special reference to the detection of human papillomaviruses. Ann Acad Med Singapore (1989) 0.75
No association between human herpesvirus 8 and arsenical skin cancers. Int J Dermatol (2001) 0.75
Patterns and implications of subclinical vulval human papillomavirus infection: the impact of PCR analysis. Asia Oceania J Obstet Gynaecol (1992) 0.75
Viruses and cancer, with particular focus on human papillomaviruses in neoplastic lesions of the cervix uteri. Ann Acad Med Singapore (1990) 0.75